Abstract
Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.
Lee JH, Park SK, Ryoo JH, Oh CM, Mansur RB, Alfonsi JE, et al. The association between insulin resistance and depression in the Korean general population. J Affect Disord. 2017;208:553–9.
Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013;36:480–9.
Phillips CM, Perry IJ. Depressive symptoms, anxiety, and well-being among metabolic health obese subtypes. Psychoneuroendocrinology 2015;62:47–53.
Dutheil S, Ota KT, Wohleb ES, Rasmussen K, Duman RS. High-fat diet induced anxiety and anhedonia: impact on brain homeostasis and inflammation. Neuropsychopharmacology 2016;41:1874–87.
Zemdegs J, Quesseveur G, Jarriault D, Pénicaud L, Fioramonti X, Guiard BP. High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice. Br J Pharm. 2016;173:2095–110.
Zemdegs J, Martin H, Pintana H, Bullich S, Manta S, Marqués MA, et al. Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids. J Neurosci. 2019;39:5935–48.
Hassan AM, Mancano G, Kashofer K, Fröhlich EE, Matak A, Mayerhofer R, et al. High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome. Nutr Neurosci. 2019;22:877–93.
Papazoglou IK, Jean A, Gertler A, Taouis M, Vacher CM. Hippocampal GSK3β as a molecular link between obesity and depression. Mol Neurobiol. 2015;52:363–74.
Martin H, Bullich S, Guiard BP, Fioramonti X. The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders. J Neuroendocrinol. 2021;33:e12928.
Kleinridders A, Cai W, Cappellucci L, Ghazarian A, Collins WR, Vienberg SG, et al. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci. 2015;112:3463–8.
Guiard BP, El Mansari M, Blier P. Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr Drug Targets. 2009;10:1069–84.
Labouèbe G, Liu S, Dias C, Zou H, Wong JCY, Karunakaran S, et al. Insulin induces long-term depression of VTA dopamine neurons via an endocannabinoid-mediated mechanism. Nat Neurosci. 2013;16:300–8.
Könner AC, Hess S, Tovar S, Mesaros A, Sánchez-Lasheras C, Evers N, et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab. 2011;13:720–8.
Evans MC, Kumar NS, Inglis MA, Anderson GM. Leptin and insulin do not exert redundant control of metabolic or emotive function via dopamine neurons. Horm Behav. 2018;106:93–104.
Yohn CN, Gergues MM, Samuels BA. The role of 5-HT receptors in depression. Mol Brain. 2017;10:28.
Kiyasova V, Fernandez SP, Laine J, Stankovski L, Muzerelle A, Doly S, et al. A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. J Neurosci J Soc Neurosci. 2011;31:2756–68.
Hanson LR, Fine JM, Svitak AL, Faltesek KA, Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 2013;74:4440.
Dhuria SV, Hanson LR, Frey WH. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99:1654–73.
Fan LW, Carter K, Bhatt A, Pang Y. Rapid transport of insulin to the brain following intranasal administration in rats. Neural Regen Res. 2019;14:1046–51.
Dellu-Hagedorn F, Fitoussi A, De Deurwaerdère P. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction. J Neurosci Methods. 2017;280:54–63.
Puginier E, Bharatiya R, Chagraoui A, Manem J, Cho YH, Garret M, et al. Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington’s disease. Neurochem Int. 2019;128:186–95.
Rainer Q, Nguyen HT, Quesseveur G, Gardier AM, David DJ, Guiard BP. Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. Mol Pharm. 2012;81:106–12.
Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, et al. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach. Neuropharmacology 2016;105:142–53.
Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, et al. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. J Neurochem. 2004;89:54–63.
Ferreira de Sá DS, Römer S, Brückner AH, Issler T, Hauck A, Michael T. Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2020;45:753–60.
Marks DR, Tucker K, Cavallin MA, Mast TG, Fadool DA. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci. 2009;29:6734–51.
Schmid V, Kullmann S, Gfrörer W, Hund V, Hallschmid M, Lipp HP, et al. Safety of intranasal human insulin: A review. Diabetes Obes Metab. 2018;20:1563–77.
Papazoglou I, Berthou F, Vicaire N, Rouch C, Markaki EM, Bailbe D, et al. Hypothalamic serotonin–insulin signaling cross-talk and alterations in a type 2 diabetic model. Mol Cell Endocrinol. 2012;350:136–44.
Portal B, Delcourte S, Rovera R, Lejards C, Bullich S, Malnou CE, et al. Genetic and pharmacological inactivation of astroglial connexin 43 differentially influences the acute response of antidepressant and anxiolytic drugs. Acta Physiol Oxf Engl. 2020;229:e13440.
MacKenzie RG, Trulson ME. Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats. J Neurochem. 1978;30:205–11.
Orosco M, Nicolaidis S. Insulin and glucose-induced changes in feeding and medial hypothalamic monoamines revealed by microdialysis in rats. Brain Res Bull. 1994;33:289–97.
Martín-Cora FJ, Fornal CA, Metzler CW, Jacobs BL. Insulin-induced hypoglycemia decreases single-unit activity of serotonergic medullary raphe neurons in freely moving cats: relationship to sympathetic and motor output: Medullary 5-HT neuronal responses to glucoregulatory challenges. Eur J Neurosci. 2002;16:722–34.
Chaput Y, de Montigny C, Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharm. 1986;333:342–8.
Czachura JF, Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharm. 2000;362:266–75.
Bosker FJ, Klompmakers A, Westenberg HGM. Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe. Eur J Pharm. 1997;333:147–57.
Martín-Ruiz R, Ugedo L. Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones. Neuropharmacology 2001;41:72–8.
Hajós M, Richards CD, Székely AD, Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 1998;87:95–108.
Craven R, Grahame-Smith D, Newberry N. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones. Eur J Pharm. 1994;271:R1–3.
Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, et al. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res. 1996;73:337–53.
Johnson DA, Gartside SE, Ingram CD. 5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus. Neuropharmacology 2002;43:959–65.
Deryabina IB, Andrianov VV, Muranova LN, Bogodvid TK, Gainutdinov KL, Effects of thryptophan hydroxylase blockade by P-Chlorophenylalanine on contextual memory reconsolidation after training of different intensity. Int J Mol Sci. 2020;21:2087.
Johnson PL, Molosh A, Fitz SD, Arendt D, Deehan GA, Federici LM, et al. Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharm Biochem Behav. 2015;138:174–9.
Engin E, Smith KS, Gao Y, Nagy D, Foster RA, Tsvetkov E, et al. Modulation of anxiety and fear via distinct intrahippocampal circuits. eLife 2016;5:e14120.
Wagle M, Zarei M, Lovett-Barron M, Poston KT, Xu J, Ramey V, et al. Brain-wide perception of the emotional valence of light is regulated by distinct hypothalamic neurons. Mol Psychiatry. 2022;1–17. Online ahead of print.
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51.
Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes. 2013;37:382.
Liu Z, Patil IY, Jiang T, Sancheti H, Walsh JP, Stiles BL, et al. High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PloS One. 2015;10:e0128274.
Kothari V, Luo Y, Tornabene T, O’Neill AM, Greene MW, Geetha T, et al. High-fat diet induces brain insulin resistance and cognitive impairment in mice. Biochim Biophys Acta Mol Basis Dis. 2017;1863:499–508.
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry. 2006;163:28–40.
Blier P, Ward H. Toward optimal treatments for major depression. CNS Spectr. 2002;7:148–50. 153–4
Poggini S, Golia MT, Alboni S, Milior G, Sciarria LP, Viglione A, et al. Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus. Neural Plast. 2019;2019:1–12.
Acknowledgements
XF and HM thank Région Nouvelle-Aquitaine and INRAE for their support. XF has been supported by the Société Française du Diabète and the Fondation Université de Bordeaux. Authors are thankful to the Fondation pour la Recerche Médicale (FRM, SL) and for the RRI Food4BrainHealth (HM, SL, XF). We thank INSERM (SJ, DC), ANR-17-CE14–0007 BABrain (to DC), and ANR-18-CE14-0029 MitObesity (to DC) for their support. AK has been supported by the Deutsche Forschungsgemeinschaft grant project and by grants from the German Ministry of Education and Research (BMBF grant 031B0569) and the State of Brandenburg (DZD grant 82DZD00302). Authors are grateful to Pr. Vanessa H. Routh (Rutgers University, NJ, USA) and Pr. Thierry Alquier (University of Montreal, Canada) for their insightful comments on the manuscript.
Author information
Authors and Affiliations
Contributions
HM, and SB designed and performed experiments. MM, MC, MDM, VS, SJ, JB, MS, and SC performed experiments. FC, AK, DC, PDD, LP, and SL edited the manuscript. BG and XF designed the project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Martin, H., Bullich, S., Martinat, M. et al. Insulin modulates emotional behavior through a serotonin-dependent mechanism. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01812-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-022-01812-3
This article is cited by
-
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Signal Transduction and Targeted Therapy (2024)
-
Vitamin D modulation of brain-gut-virome disorder caused by polystyrene nanoplastics exposure in zebrafish (Danio rerio)
Microbiome (2023)
-
Sleep-associated insulin resistance promotes neurodegeneration
Molecular Biology Reports (2023)